ArticleJournal of clinical medicine research2026
Significant Associations of Achilles Tendon Thickness With Atherosclerotic Diseases and Atherosclerotic Risk Factors in Non-Familial Hypercholesterolemia Patients: A Cross-Sectional Study.
Article in Journal of clinical medicine research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Achilles tendon thickness (ATT) is an important diagnostic tool for familial hypercholesterolemia (FH), a highly atherogenic genetic disorder. Although the available evidence remains limited, recent studies have reported associations between ATT and atherosclerotic diseases and their risk factors among non-FH patients. We investigated the relationships among ATT, carotid intima-media thickness (IMT), a marker of systemic atherosclerosis, and atherosclerotic risk factors, including diabetes, dyslipidemia, and atherosclerotic diseases, in non-FH patients. Methods: This cross-sectional survey was conducted at the National Kohnodai Medical Center, Japan. Patients who underwent ultrasonographic measurements of both ATT and carotid IMT were included. Clinical data were obtained using medical records and included demographic characteristics, anthropometric measurements, blood pressure, comorbidities, and biochemical parameters. Results: A total of 1,000 patients (512 males, 488 females) were enrolled. The mean age was 65 ± 14 years, the mean body mass index (BMI) was 24.6 ± 4.9 kg/m Conclusion: ATT levels were significantly associated with BMI and dyslipidemia, and were significantly higher in non-FH patients with CAD, carotid artery stenosis, and diabetes than in non-FH patients without such diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.